• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

O6-Benzylguanine Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5758427

O6-Benzylguanine is a guanine analog with antineoplastic activity, and is a potent O6-alkylguanine DNA alkyltransferase (AGT) inactivator. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
O6-Benzylguanine, Inhibitor
Full Product Name
O6-Benzylguanine
Form/Format
Solid
Purity/Purification
98%
Preparation and Storage
Store at -20°C.
Molecular Weight
241.25
Solubility
DMSO: 48mg/mL (198.96mM)
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C12H11N5O
CAS Number
19916-73-5
Target(IC50)
Apoptosis,DNA Alkylation,DNA/RNA Synthesis
HNMR
Consistent with structure
Conclusion
The product has been tested and meets the given quality standard.
Preparing Stock Solutions
1mM: 4.1451mL (1mg); 20.7254mL (5mg); 41.4508mL (10mg)
5mM: 0.829mL (1mg); 4.1451mL (5mg); 8.2902mL (10mg)
10mM: 0.4145mL(1mg); 2.0725mL (5mg); 4.1451mL (10mg)
50mM: 0.0829mL (1mg); 0.4145mL (5mg); 0.829mL (10mg)

Please select the appropriate solvent to prepare the stock solution, according to the solubility of the product in different solvents. Please use it as soon as possible.

Product References and Citations for O6-Benzylguanine, inhibitor

Tacastacas J D, Chan D V, Carlson S. Evaluation of O6-Benzylguanine-Potentiated Topical Carmustine for Mycosis FungoidesA Phase 1-2 Clinical Trial[J]. JAMA Dermatology, 2017, 153(5):pags. 413-420.
Tacastacas J D, Chan D V, Carlson S. Evaluation of O6-Benzylguanine-Potentiated Topical Carmustine for Mycosis FungoidesA Phase 1-2 Clinical Trial[J]. JAMA Dermatology, 2017, 153(5):pags. 413-420.
Dolan M E, Pegg A E. O6-Benzylguanine and its role in chemotherapy[J]. Clinical Cancer Research, 1997, 3(6):837-847.
Dolan M E, Pegg A E. O6-Benzylguanine and its role in chemotherapy[J]. Clinical Cancer Research, 1997, 3(6):837-847.

Other Notes

Small volumes of O6-Benzylguanine, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for O6-Benzylguanine purchase

MBS5758427 is an inhibitor targeting O6-Benzylguanine.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000